ALEXANDRA MCBREAIRTY: Open Payments
NPI 1710452396 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 75 payments from 15 companies in 2025. Trend: 2023 $1,812 · 2024 $3,096 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $492 |
| Exact Sciences Corporation | 5 | $107 |
| GlaxoSmithKline, LLC. | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Novo Nordisk Inc | 4 | $89 |
| PFIZER INC. | 4 | $79 |
| Inspire Medical Systems, Inc. | 2 | $68 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Esperion Therapeutics, Inc. | 1 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
Products named: VRAYLAR, QULIPTA, Wegovy, TRELEGY ELLIPTA, UBRELVY, INSPIRE, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across CT — which companies pay providers there.
